Strategies for Delivery of siRNAs to Ovarian Cancer Cells.
Ontology highlight
ABSTRACT: The unmet need for novel therapeutic options for ovarian cancer (OC) deserves further investigation. Among the different novel drugs, small interfering RNAs (siRNAs) are particularly attractive because of their specificity of action and efficacy, as documented in many experimental setups. However, the fragility of these molecules in the biological environment necessitates the use of delivery materials able to protect them and possibly target them to the cancer cells. Among the different delivery materials, those based on polymers and lipids are considered very interesting because of their biocompatibility and ability to carry/deliver siRNAs. Despite these features, polymers and lipids need to be engineered to optimize their delivery properties for OC. In this review, we concentrated on the
SUBMITTER: Farra R
PROVIDER: S-EPMC6835428 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA